RAND's divisions conduct research on a uniquely broad front for clients around the globe.
Commentary
Jul 8, 2022
Feb 15, 2023
Most relevant regions
Research
Mar 31, 2025
ROS forms are inconsistently operationalized and defined, with misunderstandings across both clinicians and the public. Simultaneously, the forms create additional burden across individuals involved in care delivery, including patients and families.
Video
Mar 12, 2025
RAND authors discuss the use of artificial intelligence in health care and summarize the evidence on the effects of these applications.
Feb 20, 2025
The health equity checklist provides a practical guide for researchers, community partners, and participants to reflect on inclusivity, cultural relevance, and social justice in health research.
Feb 3, 2025
AI-enabled research might cause immense harm if it is used to design pathogens with worrying new properties. To prevent this, we need better collaboration between governments, AI developers and experts in biosafety and biosecurity.
Jan 30, 2025
This chapter describes ethical issues and regulatory requirements for assent in pediatric populations.
Jan 21, 2025
Homeopathy (a widely used system of therapeutics) lacks a comprehensive robust evidence base. We examined the internal, external, and model validity of current homeopathic clinical research and an expert panel identified gaps and future priorities.
Press
Jan 7, 2025
The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study.
Dec 26, 2024
Genomics holds significant potential for conservationists. We argue that conservationists should engage with diverse communities, particularly those historically marginalized and most vulnerable to climate change.
Dec 23, 2024
The ongoing H5N1 outbreak presents a critical test of America's ability to apply the hard-earned lessons of recent health emergencies. The time to act is not when the threat becomes unmanageable—it is now, when swift, coordinated efforts can make the greatest impact.
Project
Nov 15, 2024
RAND Europe and Vitae have been commissioned by UKRI and BEIS to evaluate the UK government's COVID-19 research stabilisation interventions.
Nov 4, 2024
This is a protocol for a scoping review that will synthesize the literature on patient and other knowledge user engagement in consensus-building healthcare initiatives.
Sep 30, 2024
RAND Europe was commissioned by Ferring Pharmaceuticals to undertake an independent study to identify and characterise the challenges in the care pathway for patients with C. difficile infection and to consider key areas for improvement in the care patients receive.
